Global Rapid Acting Insulins Market Growth (Status and Outlook) 2025-2031

September 2025 | 73 pages | ID: GFC6E4E2A97EN
LP Information

Abstracts

According to this study, the global Rapid Acting Insulins market size will reach US$ million by 2031.

Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump.

United States market for Rapid Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Rapid Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Rapid Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Rapid Acting Insulins players cover Eli Lilly, Novo Nordisk, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Rapid Acting Insulins Industry Forecast” looks at past sales and reviews total world Rapid Acting Insulins sales in 2024, providing a comprehensive analysis by region and market sector of projected Rapid Acting Insulins sales for 2025 through 2031. With Rapid Acting Insulins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Acting Insulins industry.

This Insight Report provides a comprehensive analysis of the global Rapid Acting Insulins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rapid Acting Insulins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Acting Insulins market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Acting Insulins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Acting Insulins.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Acting Insulins market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Lispro
• Aspart (NovoLog)
• Glulisine (Apidra)

Segmentation by Application:

• Type 1 Diabetes
• Type 2 Diabetes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Novo Nordisk
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rapid Acting Insulins Market Size (2020-2031)
  2.1.2 Rapid Acting Insulins Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Rapid Acting Insulins by Country/Region (2020, 2024 & 2031)
2.2 Rapid Acting Insulins Segment by Type
  2.2.1 Lispro
  2.2.2 Aspart (NovoLog)
  2.2.3 Glulisine (Apidra)
2.3 Rapid Acting Insulins Market Size by Type
  2.3.1 Rapid Acting Insulins Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
2.4 Rapid Acting Insulins Segment by Application
  2.4.1 Type 1 Diabetes
  2.4.2 Type 2 Diabetes
2.5 Rapid Acting Insulins Market Size by Application
  2.5.1 Rapid Acting Insulins Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Rapid Acting Insulins Market Size Market Share by Application (2020-2025)

3 RAPID ACTING INSULINS MARKET SIZE BY PLAYER

3.1 Rapid Acting Insulins Market Size Market Share by Player
  3.1.1 Global Rapid Acting Insulins Revenue by Player (2020-2025)
  3.1.2 Global Rapid Acting Insulins Revenue Market Share by Player (2020-2025)
3.2 Global Rapid Acting Insulins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RAPID ACTING INSULINS BY REGION

4.1 Rapid Acting Insulins Market Size by Region (2020-2025)
4.2 Global Rapid Acting Insulins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rapid Acting Insulins Market Size Growth (2020-2025)
4.4 APAC Rapid Acting Insulins Market Size Growth (2020-2025)
4.5 Europe Rapid Acting Insulins Market Size Growth (2020-2025)
4.6 Middle East & Africa Rapid Acting Insulins Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Rapid Acting Insulins Market Size by Country (2020-2025)
5.2 Americas Rapid Acting Insulins Market Size by Type (2020-2025)
5.3 Americas Rapid Acting Insulins Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rapid Acting Insulins Market Size by Region (2020-2025)
6.2 APAC Rapid Acting Insulins Market Size by Type (2020-2025)
6.3 APAC Rapid Acting Insulins Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rapid Acting Insulins Market Size by Country (2020-2025)
7.2 Europe Rapid Acting Insulins Market Size by Type (2020-2025)
7.3 Europe Rapid Acting Insulins Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rapid Acting Insulins by Region (2020-2025)
8.2 Middle East & Africa Rapid Acting Insulins Market Size by Type (2020-2025)
8.3 Middle East & Africa Rapid Acting Insulins Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RAPID ACTING INSULINS MARKET FORECAST

10.1 Global Rapid Acting Insulins Forecast by Region (2026-2031)
  10.1.1 Global Rapid Acting Insulins Forecast by Region (2026-2031)
  10.1.2 Americas Rapid Acting Insulins Forecast
  10.1.3 APAC Rapid Acting Insulins Forecast
  10.1.4 Europe Rapid Acting Insulins Forecast
  10.1.5 Middle East & Africa Rapid Acting Insulins Forecast
10.2 Americas Rapid Acting Insulins Forecast by Country (2026-2031)
  10.2.1 United States Market Rapid Acting Insulins Forecast
  10.2.2 Canada Market Rapid Acting Insulins Forecast
  10.2.3 Mexico Market Rapid Acting Insulins Forecast
  10.2.4 Brazil Market Rapid Acting Insulins Forecast
10.3 APAC Rapid Acting Insulins Forecast by Region (2026-2031)
  10.3.1 China Rapid Acting Insulins Market Forecast
  10.3.2 Japan Market Rapid Acting Insulins Forecast
  10.3.3 Korea Market Rapid Acting Insulins Forecast
  10.3.4 Southeast Asia Market Rapid Acting Insulins Forecast
  10.3.5 India Market Rapid Acting Insulins Forecast
  10.3.6 Australia Market Rapid Acting Insulins Forecast
10.4 Europe Rapid Acting Insulins Forecast by Country (2026-2031)
  10.4.1 Germany Market Rapid Acting Insulins Forecast
  10.4.2 France Market Rapid Acting Insulins Forecast
  10.4.3 UK Market Rapid Acting Insulins Forecast
  10.4.4 Italy Market Rapid Acting Insulins Forecast
  10.4.5 Russia Market Rapid Acting Insulins Forecast
10.5 Middle East & Africa Rapid Acting Insulins Forecast by Region (2026-2031)
  10.5.1 Egypt Market Rapid Acting Insulins Forecast
  10.5.2 South Africa Market Rapid Acting Insulins Forecast
  10.5.3 Israel Market Rapid Acting Insulins Forecast
  10.5.4 Turkey Market Rapid Acting Insulins Forecast
10.6 Global Rapid Acting Insulins Forecast by Type (2026-2031)
10.7 Global Rapid Acting Insulins Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Rapid Acting Insulins Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Rapid Acting Insulins Product Offered
  11.1.3 Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Novo Nordisk
  11.2.1 Novo Nordisk Company Information
  11.2.2 Novo Nordisk Rapid Acting Insulins Product Offered
  11.2.3 Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novo Nordisk Main Business Overview
  11.2.5 Novo Nordisk Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Rapid Acting Insulins Product Offered
  11.3.3 Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rapid Acting Insulins Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Rapid Acting Insulins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lispro
Table 4. Major Players of Aspart (NovoLog)
Table 5. Major Players of Glulisine (Apidra)
Table 6. Rapid Acting Insulins Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Rapid Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
Table 9. Rapid Acting Insulins Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Rapid Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Rapid Acting Insulins Market Size Market Share by Application (2020-2025)
Table 12. Global Rapid Acting Insulins Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Rapid Acting Insulins Revenue Market Share by Player (2020-2025)
Table 14. Rapid Acting Insulins Key Players Head office and Products Offered
Table 15. Rapid Acting Insulins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Rapid Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Rapid Acting Insulins Market Size Market Share by Region (2020-2025)
Table 20. Global Rapid Acting Insulins Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Rapid Acting Insulins Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Rapid Acting Insulins Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Rapid Acting Insulins Market Size Market Share by Country (2020-2025)
Table 24. Americas Rapid Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
Table 26. Americas Rapid Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Rapid Acting Insulins Market Size Market Share by Application (2020-2025)
Table 28. APAC Rapid Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Rapid Acting Insulins Market Size Market Share by Region (2020-2025)
Table 30. APAC Rapid Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Rapid Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Rapid Acting Insulins Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Rapid Acting Insulins Market Size Market Share by Country (2020-2025)
Table 34. Europe Rapid Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Rapid Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Rapid Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Rapid Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Rapid Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Rapid Acting Insulins
Table 40. Key Market Challenges & Risks of Rapid Acting Insulins
Table 41. Key Industry Trends of Rapid Acting Insulins
Table 42. Global Rapid Acting Insulins Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Rapid Acting Insulins Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Rapid Acting Insulins Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Rapid Acting Insulins Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Eli Lilly Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 47. Eli Lilly Rapid Acting Insulins Product Offered
Table 48. Eli Lilly Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Eli Lilly Main Business
Table 50. Eli Lilly Latest Developments
Table 51. Novo Nordisk Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 52. Novo Nordisk Rapid Acting Insulins Product Offered
Table 53. Novo Nordisk Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Novo Nordisk Main Business
Table 55. Novo Nordisk Latest Developments
Table 56. Sanofi Details, Company Type, Rapid Acting Insulins Area Served and Its Competitors
Table 57. Sanofi Rapid Acting Insulins Product Offered
Table 58. Sanofi Rapid Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Sanofi Main Business
Table 60. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rapid Acting Insulins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rapid Acting Insulins Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Rapid Acting Insulins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Rapid Acting Insulins Sales Market Share by Country/Region (2024)
Figure 8. Rapid Acting Insulins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Rapid Acting Insulins Market Size Market Share by Type in 2024
Figure 10. Rapid Acting Insulins in Type 1 Diabetes
Figure 11. Global Rapid Acting Insulins Market: Type 1 Diabetes (2020-2025) & ($ millions)
Figure 12. Rapid Acting Insulins in Type 2 Diabetes
Figure 13. Global Rapid Acting Insulins Market: Type 2 Diabetes (2020-2025) & ($ millions)
Figure 14. Global Rapid Acting Insulins Market Size Market Share by Application in 2024
Figure 15. Global Rapid Acting Insulins Revenue Market Share by Player in 2024
Figure 16. Global Rapid Acting Insulins Market Size Market Share by Region (2020-2025)
Figure 17. Americas Rapid Acting Insulins Market Size 2020-2025 ($ millions)
Figure 18. APAC Rapid Acting Insulins Market Size 2020-2025 ($ millions)
Figure 19. Europe Rapid Acting Insulins Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Rapid Acting Insulins Market Size 2020-2025 ($ millions)
Figure 21. Americas Rapid Acting Insulins Value Market Share by Country in 2024
Figure 22. United States Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Rapid Acting Insulins Market Size Market Share by Region in 2024
Figure 27. APAC Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 28. APAC Rapid Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 29. China Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 33. India Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Rapid Acting Insulins Market Size Market Share by Country in 2024
Figure 36. Europe Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 37. Europe Rapid Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 38. Germany Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 39. France Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Rapid Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Rapid Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 52. APAC Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 53. Europe Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 55. United States Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 56. Canada Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 57. Mexico Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 58. Brazil Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 59. China Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 60. Japan Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 61. Korea Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 63. India Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 64. Australia Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 65. Germany Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 66. France Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 67. UK Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 68. Italy Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 69. Russia Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 70. Egypt Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 71. South Africa Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 72. Israel Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 73. Turkey Rapid Acting Insulins Market Size 2026-2031 ($ millions)
Figure 74. Global Rapid Acting Insulins Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Rapid Acting Insulins Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Rapid Acting Insulins Market Size 2026-2031 ($ millions)